Home/Arovella/Jacqui Cumming
JC

Jacqui Cumming

Senior Director Clinical Development

Arovella

Therapeutic Areas

Arovella Pipeline

DrugIndicationPhase
ALA-101CD19+ B‑cell lymphomas and leukaemiasPreclinical
ALA-105Claudin‑18.2+ gastric, gastro‑oesophageal junction, and pancreatic cancersPreclinical